We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$535M
AUM Growth
+$69.3M
(+15%)
Cap. Flow
+$21.1M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
688
New
58
Increased
157
Reduced
267
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$60M |
| 2 |
PepsiCo
PEP
|
+$9.31M |
| 3 |
TechnipFMC
FTI
|
+$8.19M |
| 4 |
WisdomTree India Earnings Fund ETF
EPI
|
+$7.88M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$14.4M |
| 2 |
Stellantis
STLA
|
+$8.39M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$7.31M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$6.57M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$6.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.57% |
| 2 | Technology | 5.11% |
| 3 | Consumer Discretionary | 4.59% |
| 4 | Materials | 4.47% |
| 5 | Energy | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTM
126
DELISTED
Tata Motors Limited
TTM
| $585K | 0.11% |
18,721
+3,711
| +25% | +$119K |
|
127
Teva Pharmaceuticals
TEVA
$35.9B
| $571K | 0.11% |
+32,467
| New | +$731K |
|
128
CALL
AB InBev
BUD
$158B
| $553K | 0.1% |
909
+228
| +33% | +$26.7K |
|
|
129
PUT
AB InBev
BUD
$158B
| $553K | 0.1% |
705
+452
| +179% | +$52.9K |
|
130
TripAdvisor
TRIP
$1.59B
| $548K | 0.1% |
13,535
+184
| +1% | +$7.47K |
|
131
Cisco
CSCO
$450B
| $531K | 0.1% |
15,928
+911
| +6% | +$29K |
|
132
Freeport-McMoran
FCX
$90B
| $528K | 0.1% |
+37,627
| New | +$529K |
|
|
FNSR
133
DELISTED
Finisar Corp
FNSR
| $520K | 0.1% |
+23,468
| New | +$575K |
|
134
Kimberly-Clark
KMB
$36.4B
| $503K | 0.09% |
4,275
+841
| +24% | +$103K |
|
135
Alamos Gold
AGI
$12.4B
| $491K | 0.09% |
72,629
-27,746
| -28% | -$204K |
|
136
Annaly Capital Management
NLY
$16.9B
| $486K | 0.09% |
9,974
+872
| +10% | +$42.7K |
|
137
Transocean
RIG
$5.92B
| $484K | 0.09% |
44,984
-3,876
| -8% | -$33.4K |
|
138
Fluor
FLR
$7.29B
| $476K | 0.09% |
+11,317
| New | +$469K |
|
|
EVHC
139
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $475K | 0.09% |
+10,574
| New | +$564K |
|
140
Bath & Body Works
BBWI
$4.01B
| $471K | 0.09% |
14,015
+10,815
| +338% | +$363K |
|
|
FMSA
141
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $465K | 0.09% |
97,354
+9,444
| +11% | +$30.6K |
|
142
Corning
GLW
$126B
| $459K | 0.09% |
15,359
+1,354
| +10% | +$40.1K |
|
143
CALL
Ferrari
RACE
$63.3B
| $438K | 0.08% |
105
-240
| -70% | -$25.6K |
|
|
144
PUT
Ferrari
RACE
$63.3B
| $438K | 0.08% |
649
+434
| +202% | +$46.2K |
|
145
Honeywell
HON
$77.1B
| $422K | 0.08% |
3,294
-637
| -16% | -$79K |
|
146
Lowe's Companies
LOW
$116B
| $412K | 0.08% |
5,155
+1,575
| +44% | +$121K |
|
|
CA
147
DELISTED
CA, Inc.
CA
| $401K | 0.08% |
12,016
+1,201
| +11% | +$39.7K |
|
148
PG&E
PCG
$47.8B
| $395K | 0.07% |
5,805
-1,911
| -25% | -$131K |
|
149
Southwest Airlines
LUV
$22.1B
| $391K | 0.07% |
6,981
+6,978
| +232,600% | +$392K |
|
150
Snap
SNAP
$7.32B
| $382K | 0.07% |
26,293
-37,844
| -59% | -$548K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2017 Portfolio in Review
As of Q3 2017, Exane Derivatives held 688 positions worth $535M, up 15% from $466M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Exane Derivatives deployed $21.1M of net new capital in Q3 2017, opening 58 new positions and adding to 157 existing holdings. Its largest new stake was PepsiCo: 80,581 shares worth $8.98M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Deutsche Bank, an estimated $14.4M trimmed.
- Exane Derivatives's largest Q3 2017 buy was PepsiCo: 80,581 shares worth $8.98M.
- Exane Derivatives added most to UBS Group in Q3 2017, an estimated $60M increase.
- Exane Derivatives's biggest Q3 2017 reduction was Deutsche Bank, cutting an estimated $14.4M.
- Exane Derivatives fully exited Stellantis in Q3 2017, selling an estimated $8.39M.
- Exane Derivatives's ten largest holdings make up 50% of its $535M portfolio in Q3 2017.
- Exane Derivatives opened 58 new positions and closed 121 in Q3 2017.
- Exane Derivatives's portfolio value rose 15% quarter-over-quarter to $535M.
Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.